Correspondence on "development and validation of a nomogram to predict the efficacy of PD-1/PD-L1 inhibitors in patients with nasopharyngeal carcinoma"

被引：0
|
作者：
Ragavendran, Chinnasamy [1 ]
机构：
[1] Saveetha Inst Med & Tech Sci SIMATS, Saveetha Dent Coll & Hosp, Dept Cariol, Chennai 600077, India
来源：
CLINICAL & TRANSLATIONAL ONCOLOGY | 2024年
关键词：
D O I：
10.1007/s12094-024-03808-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1853 / 1854
页数：2
相关论文
共 50 条
  • [41] PD-1/PD-L1 inhibitors increase risk of hepatitis
    Reactions Weekly, 2020, 1809 (1) : 9 - 9
  • [42] Combination therapy with PD-1 or PD-L1 inhibitors for cancer
    Hayashi, Hidetoshi
    Nakagawa, Kazuhiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (05) : 818 - 830
  • [43] Progress on biphenyl derivatives as PD-1/PD-L1 inhibitors
    Wang, Shurong
    Wang, Yuli
    Yan, Hong
    MEDICINAL CHEMISTRY RESEARCH, 2023, 32 (10) : 2089 - 2115
  • [44] Combination therapy with PD-1 or PD-L1 inhibitors for cancer
    Hidetoshi Hayashi
    Kazuhiko Nakagawa
    International Journal of Clinical Oncology, 2020, 25 : 818 - 830
  • [45] Efficiency of PD-1 and PD-L1 Inhibitors in Malignant Therapy
    Gappa, Birgit
    Kobold, Sebastian
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (01) : 7 - 8
  • [46] Combinations of Chemotherapy and PD-1/PD-L1 Inhibitors in Sarcoma
    Meghan M. Lynch
    Borislav A. Alexiev
    Brett A. Schroeder
    Seth M. Pollack
    Current Treatment Options in Oncology, 2022, 23 : 1861 - 1876
  • [47] PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
    Liu, Jinhua
    Chen, Zichao
    Li, Yaqun
    Zhao, Wenjie
    Wu, JiBiao
    Zhang, Zhen
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [48] Research progress on PD-1 and PD-L1 inhibitors in the treatment of metastatic urothelial carcinoma
    Tang, Quanqing
    Li, Shihao
    Huang, Gaozhen
    Liu, Hongwei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 119
  • [49] Combinations of Chemotherapy and PD-1/PD-L1 Inhibitors in Sarcoma
    Lynch, Meghan M.
    Alexiev, Borislav A.
    Schroeder, Brett A.
    Pollack, Seth M.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (12) : 1861 - 1876
  • [50] Update on PD-1/PD-L1 Inhibitors in Multiple Myeloma
    Jelinek, Tomas
    Paiva, Bruno
    Hajek, Roman
    FRONTIERS IN IMMUNOLOGY, 2018, 9
12345